MMP2 and breast carcinoma: Although in our study we did not found a significant correlation of rs243865 in MMP-2 with breast cancer risk, the TT genotype found to be less frequent among cases than in controls (4,3% vs. 8.4%, Table 2), what is consistent with the previous findings [50–52].